BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35975176)

  • 1. Comprehensive Analysis of Genomic and Expression Data Identified Potential Markers for Predicting Prognosis and Immune Response in CRC.
    He Y; Dai X; Chen Y; Huang S
    Genet Res (Camb); 2022; 2022():1831211. PubMed ID: 35975176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer subtyping and immune landscape analysis based on natural killer cell-related genes.
    Ding M; Gao J; Wang J; Li Z; Gong X; Cui Z; Li C; Xue H; Li D; Wang Y
    Arab J Gastroenterol; 2024 May; 25(2):150-159. PubMed ID: 38719664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of colorectal carcinoma subtypes based on ferroptosis-associated molecular markers.
    Yue Q; Zhang Y; Wang F; Cao F; Duan X; Bai J
    World J Surg Oncol; 2022 Apr; 20(1):117. PubMed ID: 35410338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
    Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
    Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
    Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
    Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel TGF-β-Related Signature for Predicting Prognosis, Tumor Microenvironment, and Therapeutic Response in Colorectal Cancer.
    Tao B; Yi C; Ma Y; Li Y; Zhang B; Geng Y; Chen Z; Ma X; Chen J
    Biochem Genet; 2023 Dec; ():. PubMed ID: 38062276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtyping and prognostic model construction based on vesicle-mediated transport-related genes in colorectal cancer.
    Wu W; Huang T; Li S; Gong G; Zhao D; Qiu Y
    Hum Mol Genet; 2024 Feb; 33(6):478-490. PubMed ID: 37971354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Autophagy in Tumor Immune Infiltration in Colorectal Cancer.
    Bian-Fang Y; Dong-Ning W; Dan T; Jian-Yu S; Shi-Yi W; Ben-Jun W; Xin D; Wen-Wen Z; Qing-Feng W; Yan Z
    Anal Cell Pathol (Amst); 2022; 2022():2055676. PubMed ID: 35321516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
    Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
    BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis.
    Wu JB; Sarmiento AL; Fiset PO; Lazaris A; Metrakos P; Petrillo S; Gao ZH
    World J Gastroenterol; 2019 Jul; 25(26):3408-3425. PubMed ID: 31341365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive functional genomic analyses link APC somatic mutation and mRNA-miRNA networks to the clinical outcome of stage-III colorectal cancer patients.
    Chiang SF; Huang HH; Tsai WS; Chin-Ming Tan B; Yang CY; Huang PJ; Yi-Feng Chang I; Lin J; Lu PS; Chin E; Liu YH; Yu JS; Chiang JM; Hung HY; You JF; Liu H
    Biomed J; 2022 Apr; 45(2):347-360. PubMed ID: 35550340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis.
    He SY; Li YC; Wang Y; Peng HL; Zhou CL; Zhang CM; Chen SL; Yin JF; Lin M
    World J Gastroenterol; 2022 Jul; 28(25):2920-2936. PubMed ID: 35978873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer.
    Yu J; Wu WK; Li X; He J; Li XX; Ng SS; Yu C; Gao Z; Yang J; Li M; Wang Q; Liang Q; Pan Y; Tong JH; To KF; Wong N; Zhang N; Chen J; Lu Y; Lai PB; Chan FK; Li Y; Kung HF; Yang H; Wang J; Sung JJ
    Gut; 2015 Apr; 64(4):636-45. PubMed ID: 24951259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of Circadian Clock Genes Associated with Tumor Immunity and Prognosis in Patients with Colon Cancer.
    He Y; Chen Y; Dai X; Huang S
    Comput Math Methods Med; 2022; 2022():4957996. PubMed ID: 35880088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
    Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
    Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New genetic variations discovered in KRAS wild-type cetuximab resistant chinese colorectal cancer patients.
    Jing C; Wang T; Ma R; Cao H; Wang Z; Liu S; Chen D; Zhang J; Wu Y; Zhang Y; Wu J; Feng J
    Mol Carcinog; 2020 May; 59(5):478-491. PubMed ID: 32141150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.